Sutimlimab

Sutimlimab
Monoclonal antibody
TypeWhole antibody
SourceChimeric/humanized hybrid
Targetcomplement component 1s
Clinical data
Trade namesEnjaymo
Other namesBIVV009, sutimlimab-jome
License data
Routes of
administration		Intravenous infusion
Drug classComplement inhibitor
ATC code
Legal status
Legal status
Identifiers
CAS Number
DrugBank
UNII
KEGG

Sutimlimab, sold under the brand name Enjaymo, is a monoclonal antibody that is used to treat adults with cold agglutinin disease (CAD).[1][3][4] It is given by intravenous infusion.[1] Sutimlimab prevents complement-enhanced activation of autoimmune human B cells in vitro.[5]

The most common side effects include headache, high blood pressure, urinary tract infection (infection of the structures that carry urine), upper respiratory tract infection (nose and throat infection), nasopharyngitis (inflammation of the nose and throat), nausea, abdominal pain, infusion-related reactions and cyanosis (bluish discoloration of hands and feet in response to cold and stress).[2]

This medication is being developed by Bioverativ, a Sanofi company.[6] Sutimlimab was approved for medical use in the United States in February 2022,[3][7] and in the European Union in November 2022.[2] The US Food and Drug Administration (FDA) considers it to be a first-in-class medication.[8][9]

Medical uses

Sutimlimab is indicated to decrease the need for red blood cell transfusion due to hemolysis (red blood cell destruction) in adults with cold agglutinin disease (CAD).[1][3]

Adverse effects

The most common side effects include respiratory tract infection, viral infection, diarrhea, dyspepsia (indigestion), cough, arthralgia (joint stiffness), arthritis, and swelling in the lower legs and hands.[3] In two phase 3 studies (n=66), 29% of patients experienced infusion-related reactions, including shortness of breath, rapid heartbeat, nausea, flushing, headache, hypotension, chest discomfort, pruritis, rash, injection site reaction, and dizziness.[10]

Pharmacology

Mechanism of action

Sutimlimab targets the C1s enzyme and inhibits its enzymatic propagation of the classical complement pathway, thereby, preventing the formation of the C3-convertase enzyme.[11]

History

The effectiveness of sutimlimab was assessed in a study of 24 adults with cold agglutinin disease who had a blood transfusion within the past six months.[3] All participants received sutimlimab for up to six months and could choose to continue therapy in a second part of the trial.[3] Based on body weight, participants received either a 6.5 g or 7.5 g infusion of sutimlimab into their vein on day 0, day 7, and every 14 days through week 25.[3]

In total, 54% of participants responded to sutimlimab.[3] The response was defined in the study as an increase in hemoglobin (an indirect measurement of the amount of red blood cells that are not destroyed) of 2 g/dL or greater (or to 12 g/dL or greater), and no red blood cell transfusions after the first five weeks of treatment; and no other therapies for cold agglutinin disease as defined in the study.[3]

The US Food and Drug Administration (FDA) granted the application for sutimlimab orphan drug,[3][12] breakthrough therapy,[3] and priority review designations.[3]

Society and culture

In September 2022, the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Enjaymo, intended for the treatment of hemolytic anemia in adults with cold agglutinin disease (CAD).[13] The applicant for this medicinal product is Genzyme Europe BV.[13] Sutimlimab was approved for medical use in the European Union in November 2022.[2][14]

Names

Sutimlimab is the International nonproprietary name (INN).[15]

References

  1. ^ a b c d "Enjaymo- sutimlimab injection, solution, concentrate". DailyMed. 1 February 2022. Archived from the original on 21 February 2022. Retrieved 20 February 2022.
  2. ^ a b c d "Enjaymo EPAR". European Medicines Agency (EMA). 14 September 2022. Retrieved 4 March 2023. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
  3. ^ a b c d e f g h i j k l "FDA approves treatment for adults with rare type of anemia". U.S. Food and Drug Administration. 4 February 2022. Archived from the original on 6 February 2022. Retrieved 6 February 2022. Public Domain This article incorporates text from this source, which is in the public domain.
  4. ^ Tvedt TH, Steien E, Øvrebø B, Haaverstad R, Hobbs W, Wardęcki M, et al. (February 2022). "Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery". American Journal of Hematology. 97 (2): E51–E54. doi:10.1002/ajh.26409. PMID 34778998. S2CID 244116614.
  5. ^ Nikitin PA, Rose EL, Byun TS, Parry GC, Panicker S (February 2019). "C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro". Journal of Immunology. 202 (4): 1200–1209. doi:10.4049/jimmunol.1800998. PMC 6360260. PMID 30635392.
  6. ^ "Sutimlimab FDA Approval Status". FDA. 19 May 2020. Archived from the original on 31 December 2021. Retrieved 31 December 2021.
  7. ^ "FDA approves Enjaymo (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease". Sanofi (Press release). 4 February 2022. Archived from the original on 5 February 2022. Retrieved 6 February 2022.
  8. ^ "Advancing Health Through Innovation: New Drug Therapy Approvals 2022". U.S. Food and Drug Administration (FDA). 10 January 2023. Retrieved 22 January 2023. Public Domain This article incorporates text from this source, which is in the public domain.
  9. ^ New Drug Therapy Approvals 2022 (PDF). U.S. Food and Drug Administration (FDA) (Report). January 2024. Archived from the original on 14 January 2024. Retrieved 14 January 2024. Public Domain This article incorporates text from this source, which is in the public domain.
  10. ^ FDA Professional Drug Information
  11. ^ Bartko J, Schoergenhofer C, Schwameis M, Firbas C, Beliveau M, Chang C, et al. (October 2018). "A Randomized, First-in-Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway". Clinical Pharmacology and Therapeutics. 104 (4): 655–663. doi:10.1002/cpt.1111. PMC 6175298. PMID 29737533.
  12. ^ "Sutimlimab Orphan Drug Designations and Approvals". U.S. Food and Drug Administration (FDA). 27 July 2016. Archived from the original on 7 February 2022. Retrieved 6 February 2022.
  13. ^ a b "Enjaymo: Pending EC decision". European Medicines Agency (EMA). 15 September 2022. Archived from the original on 16 September 2022. Retrieved 18 September 2022. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
  14. ^ "Enjaymo Product information". Union Register of medicinal products. Retrieved 3 March 2023.
  15. ^ World Health Organization (2018). "International nonproprietary names for pharmaceutical substances (INN): recommended INN: list 80". WHO Drug Information. 32 (3). hdl:10665/330907.
  • Clinical trial number NCT03347396 for "A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion (Cardinal Study)" at ClinicalTrials.gov

Read other articles:

Butir cokelat

Coklat chip rasa semi manis Cokelat chip adalah butir-butir cokelat kecil. Umumnya dijual dalam bentuk bulat, dan bentuk tetesan air mata yang dasarnya rata. Ukurannya pun beragam, dari yang besar sampai kecil, tetapi biasanya dijumpai yang berdiameter 1 cm. Cokelat chip dapat ditambahkan di kue kering, panekuk, wafel, puding, muffin, crêpes, pai, cokelat panas, dan berbagai macam kue basah. Cokelat chip dapat pula dijumpai di produk makanan lain seperti granula, es krim, dan trail mix....

 

5s

artikel ini tidak memiliki pranala ke artikel lain. Tidak ada alasan yang diberikan. Bantu kami untuk mengembangkannya dengan memberikan pranala ke artikel lain secukupnya. (Pelajari cara dan kapan saatnya untuk menghapus pesan templat ini) Toyota, salah satu perusahaan Jepang yang sukses menerapkan dan menyebarluaskan sistem 5S dan Kaizen Menurut Takashi Osada Manajemen 5S adalah prinsip manajemen yang merupakan barometer yang dapat menunjukan bagaimana perusahaan dikelola dan merupakan tolo...

 

Saint-Florent-sur-Cher

Pour les articles homonymes, voir Saint-Florent. Saint-Florent-sur-Cher La mairie. Blason Administration Pays France Région Centre-Val de Loire Département Cher Arrondissement Bourges Intercommunalité Communauté de communes FerCher - Pays Florentais(siège) Maire Mandat Marie-Line Cirre 2023-2026 Code postal 18400 Code commune 18207 Démographie Populationmunicipale 6 419 hab. (2021 ) Densité 286 hab./km2 Géographie Coordonnées 46° 59′ 47″ nord, 2°&...

Porcupine

This article is about the mammal. For other uses, see Porcupine (disambiguation). Rodent with a coat of sharp spines This article includes a list of references, related reading, or external links, but its sources remain unclear because it lacks inline citations. Please help improve this article by introducing more precise citations. (April 2023) (Learn how and when to remove this message) Porcupine North American porcupine Scientific classification Domain: Eukaryota Kingdom: Animalia Phylum: ...

 

Orville E. Babcock

Union Army general (1835–1884) Orville Elias BabcockOrville E. BabcockBorn(1835-12-25)December 25, 1835Franklin, Vermont, USDiedJune 2, 1884(1884-06-02) (aged 48)Mosquito Inlet, Florida, USPlace of burialArlington National CemeteryAllegianceUnited States of AmericaUnionService/branchUnited States ArmyUnion ArmyYears of service1861–1884Rank Colonel Brevet Brigadier GeneralUnitUnited States Army Corps of EngineersBattles/warsAmerican Civil War Peninsular Campaign Siege of Yorktown...

 

البريق (فيلم)

البريقThe Shining (بالإنجليزية) الشعارملصق الفيلممعلومات عامةالصنف الفني  القائمة ... فيلم رعب[1][2][3] — رعب نفسي — فيلم دراما — فيلم مقتبس من رواية — فيلم غموض — فيلم أشباح — دراما خوارق[4] المواضيع ما وراء الطبيعة — كحولية — فيلم رعب تاريخ الصدور  القائمة ....

Vaalbara

Vaalbara è il nome che è stato dato al primo supercontinente esistito sulla Terra, circa 3,3 miliardi di anni fa. La denominazione Vaalbara fu proposta da E. S. Cheney che la derivò dalle ultime quattro sillabe dei due cratoni che lo costituivano, il Cratone di Kaapvaal e il Cratone Pilbara[1]. L'esistenza di un supercontinente antecedente Vaalbara, un proto-Valbaara datante 3,6–3,2 Ga, è suggerita da alcune ricostruzioni paleomagnetiche, ma non vi sono prove certe e materi...

 

Hasso Plattner

German billionaire businessman and philanthropist Hasso PlattnerPlattner in 2010Born (1944-01-21) 21 January 1944 (age 80)Berlin, GermanyOccupation(s)Entrepreneur, philanthropistKnown forFounder of SAP SE; majority owner of the San Jose Sharks ice hockey teamTitleChairman of SAP SESpousemarriedChildren2 Hasso Plattner (born 21 January 1944) is a German businessman. A co-founder of SAP SE software company, he has been chairman of the supervisory board of SAP SE since May 2003.[1&...

 

Keuskupan Agung Bourges

Keuskupan Agung BourgesArchidioecesis BituricensisArchidiocèse de BourgesKatolik Katedral BourgesLokasiNegaraPrancisProvinsi gerejawiToursStatistikLuas14.210 km2 (5.490 sq mi)Populasi- Total- Katolik(per 2012)549.900502,700 (91.4%)Paroki64InformasiDenominasiKatolik RomaGereja sui iurisGereja LatinRitusRitus RomaPendirianAbad ke-3KatedralKatedral Santo Stefanus di BourgesPelindungSt. Ursinus dari BourgesKepemimpinan kiniPausFransiskusUskup AgungJérôme Dani...

Welsh Government traffic officer

Road transport occupation in Wales Welsh Government traffic officerSwyddog Traffig y Llywodraeth Cymru (Welsh)OccupationActivity sectorsGovernment, road traffic control, vehicle recovery, roadside assistanceDescriptionFields ofemploymentMotorways and select trunk roads in Wales operated by Trunk road agents.Related jobsRoad policing unit, Traffic guard Logo used by Welsh Government Traffic Officers Welsh Government traffic officers (Welsh: Swyddog Traffig y Llywodraeth Cymru) are civilia...

 

Türksat 4B

Türksat 4BMission typeCommunicationOperatorTürksatCOSPAR ID2015-060A SATCAT no.40984Mission duration15 years Spacecraft propertiesBusMELCO DS2000[1]ManufacturerMELCO[1]Launch mass4,924 kg (10,856 lb) Start of missionLaunch dateOctober 16, 2015, 20:40:00 (2015-10-16UTC20:40Z) UTCRocketProton-M/Breeze-MLaunch siteBaikonur Cosmodrome Pad 39, KazakhstanContractorILS Orbital parametersReference systemGeocentricRegimeGeostationaryLongitude50° East Türksa...

 

De Tomaso

Italian car manufacturing company De Tomaso Automobili Ltd.FormerlyDe Tomaso Modena SpACompany typePrivateIndustryAutomotiveFounded1959; 65 years ago (1959)FounderAlejandro de TomasoFateFiled for bankruptcy in 2012;[1] Company sold to Ideal Team Ventures in 2014[2]HeadquartersModena, Italy (1959–2004)Area servedWorldwideKey peopleNorman Choi (Chairman)[3][4]ProductsSupercarsOwnerIdeal Team Ventures LimitedParentFord (1971–1974)Subsidiaries...

Manamadurai–Rameswaram branch line

Railway line in India Manamadurai–Rameswaram branch lineTrain Passing on Pamban bridge lies on Manamadurai–Rameswaram branch lineOverviewStatusOperatingOwnerIndian RailwaysTerminiManamadurai JunctionRameswaramWebsitewww.sr.indianrailways.gov.inServiceTypeExpress trainPassenger trainOperator(s)Southern Railway zoneTechnicalLine length161 km (100 mi)Number of tracks1Track gauge1,676 mm (5 ft 6 in)Old gauge1,000 mm (3 ft 3+3⁄8 in)Loadin...

 

Indalpine

Discontinued SSRI antidepressant drug IndalpineClinical dataTrade namesUpstèneIdentifiers IUPAC name 3-(2-Piperidin-4-ylethyl)-1H-indole CAS Number63758-79-2 YPubChem CID44668DrugBankDB08953 YChemSpider40643 YUNIIV35562QSVTChEMBLChEMBL276520 YCompTox Dashboard (EPA)DTXSID80213196 ECHA InfoCard100.058.569 Chemical and physical dataFormulaC15H20N2Molar mass228.339 g·mol−13D model (JSmol)Interactive image SMILES c2(c1ccccc1[nH]c2)CCC3CCNCC3 InChI InChI=1S/C15H20N2/c1...

 

Azerbaijan at the 1996 Summer Olympics

Sporting event delegationAzerbaijan at the1996 Summer OlympicsIOC codeAZENOCNational Olympic Committee of the Azerbaijani RepublicWebsitewww.noc-aze.org (in Azerbaijani and English)in AtlantaCompetitors23 (20 men, 3 women) in 9 sportsFlag bearer Nazim HüseynovMedalsRanked 61st Gold 0 Silver 1 Bronze 0 Total 1 Summer Olympics appearances (overview)19962000200420082012201620202024Other related appearances Russian Empire (1900–1912) Soviet Union (1952–1988) Unified ...

Shot put

Track and field event AthleticsShot putPolish double Olympic champion Tomasz MajewskiWorld recordsMen Ryan Crouser 23.56 m (77 ft 3+1⁄2 in) (2023)Women Natalya Lisovskaya 22.63 m (74 ft 2+3⁄4 in) (1987)Olympic recordsMen Ryan Crouser 23.30 m (76 ft 5+1⁄4 in) (2021)Women Ilona Slupianek 22.41 m (73 ft 6+1⁄4 in) (1980)World Championship recordsMen Ryan Crouser 23.51 m (77 ft 1+1⁄2 in) (2023)...

 

Kwaza language

Endangered language spoken in Brazil Koaia language redirects here. For the language of the Mato Grosso, see Mato Grosso Arara language. Not to be confused with Kwʼadza language. KwazaKoaiáPronunciation[kwaʔða]Native toBrazilRegionRondôniaNative speakers25 (2014)[1]Language familyunclassifiedLanguage codesISO 639-3xwaGlottologkwaz1243ELPKwazaThis article contains IPA phonetic symbols. Without proper rendering support, you may see question marks, boxes, or other symbols ...

 

Mesomedes

2nd century AD Greek citharode and lyric poet Mesomedes of Crete (Ancient Greek: Μεσομήδης ὁ Κρής) was a Greek citharode and lyric poet and composer of the early 2nd century AD in Roman Greece. Prior to the discovery of the Seikilos epitaph in the late 19th century, the hymns of Mesomedes were the only surviving written music from the ancient world.[1] Three were published by Vincenzo Galilei in his Dialogo della musica antica e della moderna (Florence, 1581), during a ...

André Benedetto

Pour les articles homonymes, voir Benedetto. André Benedetto Données clés Nom de naissance André Clément Benedetto Naissance 14 juillet 1934 Marseille Décès 13 juillet 2009 (à 74 ans) Nîmes Activité principale Dramaturge, poète, metteur en scène Auteur Langue d’écriture Français, occitan Genres Théâtre, poésie Œuvres principales Napalm La petit train de Monsieur Kamodé San Jorgi Roc Urgent crier La Madone des ordures Compléments Philippe Caubère a créé lors du f...

 

فلسطين (تكساس)

  لمعانٍ أخرى، طالع فلسطين (توضيح). فلسطين     الإحداثيات 31°45′29″N 95°38′19″W / 31.758055555556°N 95.638611111111°W / 31.758055555556; -95.638611111111   [1] تاريخ التأسيس 1846  سبب التسمية باليستاين  تقسيم إداري  البلد الولايات المتحدة[2][3]  التقسيم الأعلى مقاطعة أ...